Ding et al. [97] explored another CTLX-mediated CAR T cell product co-transduced with O-6-Methylguanine-DNA Methyltransferase (MGMT) to provide CAR T resistance to alkylating chemotherapeutics commonly used in cancer treatment. This evidence concerns the gene MGMT and cancer.